HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS
Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treati...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WANG BOWEI CLARK RYAN TRUONG YEN PHAM HUTCHINSON JOHN HOWARD SEIDERS THOMAS JON SCOTT JILL MELISSA STEARNS BRIAN ANDREW VOLKOTS DEBORAH PARR TIMOTHY ANDREW COATE HEATHER RENEE ROPPE JEFFREY ROGER STOCK NICHOLAS SIMONE |
| description | Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2011312974A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2011312974A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2011312974A13</originalsourceid><addsrcrecordid>eNrjZDDxcA1xDfJ3DIr0UXD0C3F09_fzDA4JVvB3UwgI8g8GCvg4-rl4-im4GCkEuTq7BoT4BwXzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjA0NDY0MjS3MTR0Nj4lQBAIVpKI0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS</title><source>esp@cenet</source><creator>WANG BOWEI ; CLARK RYAN ; TRUONG YEN PHAM ; HUTCHINSON JOHN HOWARD ; SEIDERS THOMAS JON ; SCOTT JILL MELISSA ; STEARNS BRIAN ANDREW ; VOLKOTS DEBORAH ; PARR TIMOTHY ANDREW ; COATE HEATHER RENEE ; ROPPE JEFFREY ROGER ; STOCK NICHOLAS SIMONE</creator><creatorcontrib>WANG BOWEI ; CLARK RYAN ; TRUONG YEN PHAM ; HUTCHINSON JOHN HOWARD ; SEIDERS THOMAS JON ; SCOTT JILL MELISSA ; STEARNS BRIAN ANDREW ; VOLKOTS DEBORAH ; PARR TIMOTHY ANDREW ; COATE HEATHER RENEE ; ROPPE JEFFREY ROGER ; STOCK NICHOLAS SIMONE</creatorcontrib><description>Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2011</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111222&DB=EPODOC&CC=US&NR=2011312974A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111222&DB=EPODOC&CC=US&NR=2011312974A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WANG BOWEI</creatorcontrib><creatorcontrib>CLARK RYAN</creatorcontrib><creatorcontrib>TRUONG YEN PHAM</creatorcontrib><creatorcontrib>HUTCHINSON JOHN HOWARD</creatorcontrib><creatorcontrib>SEIDERS THOMAS JON</creatorcontrib><creatorcontrib>SCOTT JILL MELISSA</creatorcontrib><creatorcontrib>STEARNS BRIAN ANDREW</creatorcontrib><creatorcontrib>VOLKOTS DEBORAH</creatorcontrib><creatorcontrib>PARR TIMOTHY ANDREW</creatorcontrib><creatorcontrib>COATE HEATHER RENEE</creatorcontrib><creatorcontrib>ROPPE JEFFREY ROGER</creatorcontrib><creatorcontrib>STOCK NICHOLAS SIMONE</creatorcontrib><title>HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS</title><description>Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2011</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDDxcA1xDfJ3DIr0UXD0C3F09_fzDA4JVvB3UwgI8g8GCvg4-rl4-im4GCkEuTq7BoT4BwXzMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JL40GAjA0NDY0MjS3MTR0Nj4lQBAIVpKI0</recordid><startdate>20111222</startdate><enddate>20111222</enddate><creator>WANG BOWEI</creator><creator>CLARK RYAN</creator><creator>TRUONG YEN PHAM</creator><creator>HUTCHINSON JOHN HOWARD</creator><creator>SEIDERS THOMAS JON</creator><creator>SCOTT JILL MELISSA</creator><creator>STEARNS BRIAN ANDREW</creator><creator>VOLKOTS DEBORAH</creator><creator>PARR TIMOTHY ANDREW</creator><creator>COATE HEATHER RENEE</creator><creator>ROPPE JEFFREY ROGER</creator><creator>STOCK NICHOLAS SIMONE</creator><scope>EVB</scope></search><sort><creationdate>20111222</creationdate><title>HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS</title><author>WANG BOWEI ; CLARK RYAN ; TRUONG YEN PHAM ; HUTCHINSON JOHN HOWARD ; SEIDERS THOMAS JON ; SCOTT JILL MELISSA ; STEARNS BRIAN ANDREW ; VOLKOTS DEBORAH ; PARR TIMOTHY ANDREW ; COATE HEATHER RENEE ; ROPPE JEFFREY ROGER ; STOCK NICHOLAS SIMONE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2011312974A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2011</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WANG BOWEI</creatorcontrib><creatorcontrib>CLARK RYAN</creatorcontrib><creatorcontrib>TRUONG YEN PHAM</creatorcontrib><creatorcontrib>HUTCHINSON JOHN HOWARD</creatorcontrib><creatorcontrib>SEIDERS THOMAS JON</creatorcontrib><creatorcontrib>SCOTT JILL MELISSA</creatorcontrib><creatorcontrib>STEARNS BRIAN ANDREW</creatorcontrib><creatorcontrib>VOLKOTS DEBORAH</creatorcontrib><creatorcontrib>PARR TIMOTHY ANDREW</creatorcontrib><creatorcontrib>COATE HEATHER RENEE</creatorcontrib><creatorcontrib>ROPPE JEFFREY ROGER</creatorcontrib><creatorcontrib>STOCK NICHOLAS SIMONE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WANG BOWEI</au><au>CLARK RYAN</au><au>TRUONG YEN PHAM</au><au>HUTCHINSON JOHN HOWARD</au><au>SEIDERS THOMAS JON</au><au>SCOTT JILL MELISSA</au><au>STEARNS BRIAN ANDREW</au><au>VOLKOTS DEBORAH</au><au>PARR TIMOTHY ANDREW</au><au>COATE HEATHER RENEE</au><au>ROPPE JEFFREY ROGER</au><au>STOCK NICHOLAS SIMONE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS</title><date>2011-12-22</date><risdate>2011</risdate><abstract>Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists of PGD2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2011312974A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T14%3A16%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WANG%20BOWEI&rft.date=2011-12-22&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2011312974A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |